241 related articles for article (PubMed ID: 14576988)
1. Proteus mirabilis and rheumatoid arthritis: no association with the disease.
Chandrashekara S; Ramesh MN; Shobha A; Saravanan Y; Vadiraja HS; Navaneeth BV; Sandhya Belwadi MR
Clin Rheumatol; 2003 Oct; 22(4-5):268-70. PubMed ID: 14576988
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis and rheumatoid arthritis: no association with the disease.
Chandrashekara S; Ramesh MN; Shobha A; Saravanan Y; Vadiraja HS; Navaneeth BV; Sandhya Belwadi MR
Clin Rheumatol; 2003 Sep; 22(3):218-20. PubMed ID: 14505214
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis.
Blankenberg-Sprenkels SH; Fielder M; Feltkamp TE; Tiwana H; Wilson C; Ebringer A
J Rheumatol; 1998 Apr; 25(4):743-7. PubMed ID: 9558179
[TBL] [Abstract][Full Text] [Related]
6. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.
Subair H; Tiwana H; Fielder M; Binder A; Cunningham K; Ebringer A; Wilson C; Hudson MJ
J Rheumatol; 1995 Oct; 22(10):1825-8. PubMed ID: 8991977
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes.
Rashid T; Jayakumar KS; Binder A; Ellis S; Cunningham P; Ebringer A
Clin Exp Rheumatol; 2007; 25(2):259-67. PubMed ID: 17543151
[TBL] [Abstract][Full Text] [Related]
8. Selective IgA immune unresponsiveness to Proteus mirabilis fumarate reductase A-chain in rheumatoid arthritis.
Weisbart RH; Min Y; Wong AL; Kang J; Kwunyeun S; Lin A; Kim J; Chan G; Wakelin R; Sohn W; Chang SS; Nishimura RN
J Rheumatol; 2005 Jul; 32(7):1208-12. PubMed ID: 15996053
[TBL] [Abstract][Full Text] [Related]
9. Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.
Tarkowski A; Nilsson LA
J Clin Lab Immunol; 1983 Nov; 12(3):129-35. PubMed ID: 6663605
[TBL] [Abstract][Full Text] [Related]
10. Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.
Christopoulos G; Christopoulou V; Routsias JG; Babionitakis A; Antoniadis C; Vaiopoulos G
Clin Rheumatol; 2017 Mar; 36(3):527-535. PubMed ID: 27722971
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper.
Ebringer A; Rashid T; Wilson C
Autoimmun Rev; 2010 Feb; 9(4):216-23. PubMed ID: 19895906
[TBL] [Abstract][Full Text] [Related]
12. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
13. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls.
Senior BW; Anderson GA; Morley KD; Kerr MA
J Infect; 1999 Mar; 38(2):99-106. PubMed ID: 10342649
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis.
Wilson C; Rashid T; Tiwana H; Beyan H; Hughes L; Bansal S; Ebringer A; Binder A
J Rheumatol; 2003 May; 30(5):972-8. PubMed ID: 12734891
[TBL] [Abstract][Full Text] [Related]
15. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis.
Wilson C; Thakore A; Isenberg D; Ebringer A
Rheumatol Int; 1997; 16(5):187-9. PubMed ID: 9032817
[TBL] [Abstract][Full Text] [Related]
16. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-Proteus antibodies in sera of patients with rheumatoid arthritis.
Gautam V; Sehgal R; Paramjeet SG; Arora DR
Indian J Pathol Microbiol; 2003 Jan; 46(1):137-41. PubMed ID: 15027757
[TBL] [Abstract][Full Text] [Related]
18. The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity.
Chandrashekara S; Patil R; Vadiraja HS; Shobha A
Clin Rheumatol; 2006 Jul; 25(4):520-3. PubMed ID: 16267598
[TBL] [Abstract][Full Text] [Related]
19. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
[TBL] [Abstract][Full Text] [Related]
20. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis.
Wilson C; Ebringer A; Ahmadi K; Wrigglesworth J; Tiwana H; Fielder M; Binder A; Ettelaie C; Cunningham P; Joannou C
Ann Rheum Dis; 1995 Mar; 54(3):216-20. PubMed ID: 7748019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
